Australia markets open in 3 hours 44 minutes

Standard BioTools Inc. (LAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4000-0.0100 (-0.41%)
At close: 04:00PM EDT
2.3400 -0.06 (-2.50%)
After hours: 06:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.4100
Open2.4000
Bid2.3900 x 4500
Ask2.4200 x 900
Day's range2.3850 - 2.4700
52-week range1.5700 - 3.1600
Volume2,321,851
Avg. volume2,367,608
Market cap909.266M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.9400
Earnings date06 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est0.50
  • GlobeNewswire

    Standard BioTools Reports First Quarter 2024 Financial Results

    Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of approximately $21 million, and non-GAAP operating expense reduction of approximately $17 millionOn track to cash flow positive in full-year 2026 with current balance sheet of $464 million cash, cash equivalents, res

  • GlobeNewswire

    Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

    Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency and reduce operating costs, while suppo

  • GlobeNewswire

    Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

    SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the market. The Company’s management will host a conference call and webcast at 1:30 p.m. PT, 4:30 p.m. ET, on May 8, 2024, to discuss first quarter 2024 financial results and operational progress. A press release including the financial res